Bernd Muehlenweg

SVP Global Business Development at Evotec

Speaker

Building sustainable and durable partnership to advance innovative approaches into approved medications has been Bernd’s driving force throughout his career. He has more than two decades of experience in senior positions focusing on business and corporate development along with alliance management in the pharma and biotechnology industries. During this time he has been involved in establishing a broad bandwidth of collaborations to develop and commercialize assets from early research stage up to late-stage clinical development. He also founded Panoptes Pharma GmbH, a biotech start-up that was acquired by a NASDAQ listed company. Bernd serves as Senior Vice President, Head of Global Business Development, Cell Therapy at Evotec. He is also Member of the Board of Directors of Sernova Corp, a TSX listed Canadian company committed to the development and clinical advancement of regenerative medicine therapeutics for chronic diseases.